4 ms·
The way to increase efficiency over time is to develop useful tools like CRISPR not simply look for the most beneficial research to solve a specific problem. B
by Retric 7y ago
The way to increase efficiency over time is to develop useful tools like CRISPR not simply look for the most beneficial research to solve a specific problem. Bill Gates has a focus on specific goals which are extremely valuable today, but arguably shortsighted. Further, the NIH is focused on solving problems for the UK not say Ethiopia. But, as poor countries develop they start using UK style solutions not cheaper though less effective alternatives.
So it’s really a question of which metric you’re using to evaluate each system not some universal efficiency metric. Global impact over the next 20 years vs global impact over 200 years etc.
- wtvanhest 7y agoThe older I have gotten, the more I believe that short term gains are better than long term strategies because short-term gains build on each other. I don’t know the history of crispr, but I doubt it was just a single check, single project completed from start to end. I’m sure it took a lot of iteration and success of many small short-term goals
- Retric 7y agoIt’s the nature of the goals not the time it takes to reach them that I am talking about. A COVID-19 vaccine is extremely valuable today, but it becomes useless even 5 years from now. On the other hand our experience with COVID-19 is likely to spawn a great deal of research into developing vaccines faster which while useless for this epidemic could be extremely valuable for the next several. Clearly a COVID-19 vaccine could save millions of lives and is worth investing in, but it’s a specific finite number. So called basic research can save more people’s lives than are alive today.
- runako 7y ago> develop useful tools like CRISPR not simply look for the most beneficial research to solve a specific problem You're describing a 40+ year body of research as if it were a project to develop CRISPR as an endpoint. But that's nothing like the process that actually produced CRISPR. Take the Hsu et. al. paper describing CRISPR-Cas9 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4343198/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4343198/), for example. That paper cites 100 other papers, with multiple citations in each decade going back to the 1980s. (The first paper cited was published based on research that likely happened 10 years before before the sequencing of the entire genome of an organism.) And those 100 papers lean on other papers, etc. Science is not an engineering project.
- Retric 7y agoWhat I am describing is research without an immediate social or medical benefit. Also, CRISPR‘s roots go way past 40 years. Watson and Crick for example helped pave the way well over 60 years ago. A decade after their research was published a doctor may have found it interesting, but it was still a long way from being directly useful.
- runako 7y agoI think we're saying the same thing. You have to fund basic science, and you can't always do basic science with a tool like CRISPR in mind.
- joshuaissac 7y agoYour point stands, but NIH is an American agency. The British equivalent is NIHR.